Hongli Group Inc. (HLP)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Helus Pharma: APPROACHing Inflection: Pivotal Readout Sets Up Asymmetric Upside
I initiate coverage of Helus Pharma with a speculative Buy, citing an attractive high-risk/high-reward setup ahead of the pivotal Phase 3 APPROACH readout in Q4 2026. HELP's lead asset HLP003, an oral deuterated psilocin analog for adjunctive MDD, shows compelling Phase 2 efficacy, FDA Breakthrough Therapy Designation, and a differentiated clinical profile. Current valuation (~$269M EV, ~$207M pro forma cash) under-credits the probability-weighted value of HLP003, with a risk-adjusted implied EV of ~$1.5B if Phase 3 succeeds.
HELUS Pharma: Transitioning From Psychedelic Research To Late-Stage Clinical Neuroscience
HELUS Pharma has rebranded and moved to Nasdaq, signaling a shift toward late-stage clinical development and commercial focus. Key 2026 catalysts include Phase 3 data for HLP003 in major depressive disorder and Phase 2 data for HLP004 in generalized anxiety disorder. HELP's cash burn accelerated to $36.7M in 3Q26, with $195M cash on hand and a $100M ATM facility providing runway through pivotal trial milestones.
Hongli Group Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 1 | $0.88 | $1.1 | $0.22 | 25% |
Hongli Group Inc. (HLP) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Hongli Group Inc. ever had a stock split?
Hongli Group Inc. Profile
| Metals & Mining Industry | Materials Sector | Jie Liu CEO | NASDAQ (CM) Exchange | G4594M108 CUSIP |
| CN Country | 176 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Hongli Group Inc., founded in 2021, is a prominent entity headquartered in Weifang, China, that operates globally. The company, functioning through its subsidiaries, has carved a niche in the design, customization, manufacturing, and sales of cold roll formed steel profiles. These products find their applications across a broad spectrum of industries such as mining and excavation, construction, agriculture, and transportation. With a geographic reach that extends to the People's Republic of China, South Korea, Japan, the United States, and Sweden, Hongli Group Inc. demonstrates a global footprint in the industrial manufacturing sector. As a subsidiary of Hongli Development Limited, the group leverages synergies within its corporate structure to drive innovation and cater to a diverse client base worldwide.
Products and Services
- Cold Roll Formed Steel Profiles - Hongli Group Inc. specializes in the production and distribution of high-quality cold roll-formed steel profiles. These profiles are engineered to meet the precise specifications and requirements of machinery and equipment used in various industries. The cold roll forming process ensures superior durability, strength, and performance of the steel profiles, making them suitable for a wide range of industrial applications.
- Customization Services - Understanding the diverse needs of its clients, Hongli Group Inc. offers customization services that allow for the tailoring of steel profiles according to the specific demands of the machinery or equipment they are intended for. This bespoke approach facilitates optimal compatibility and functionality across different sectors, including mining and excavation, construction, agriculture, and transportation.
- Global Supply Chain - With its extensive network spanning the People’s Republic of China, South Korea, Japan, the United States, and Sweden, Hongli Group Inc. ensures a reliable and efficient supply of its products and services. This global presence not only broadens the company’s market reach but also enhances its ability to serve clients with speed and efficiency, thereby maintaining high levels of customer satisfaction.
